Home > Press > An effective, biodegradable and broad-spectrum nanoparticles as potent antibacterial agents
Abstract:
Many experimental and clinical data have demonstrated that antibiotic-resistance pathogens, such as Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), may play a vital role in priming chronic inflammation. There is thus a great need to develop novel antibacterial materials, and particularly those that are less likely to lead to bacterial resistance.
Now, in a paper appearing recently in Science Bulletin, a team of scientists at the National Center for Nanoscience and Technology, China, led by Guangjun Nie and Yuliang Zhao, has designed and synthesized biocompatible and biodegradable ε-poly-lysine (EPL)/poly (ε-caprolactone) (PCL) nanoparticles (NPs), which have effective antibacterial activity and no significant cytotoxicity to mammalian cells.
Most clinically used antibiotics do not physically damage the cell membranes/walls, but rather target the cell wall and penetrate into the cell, inhibiting protein synthesis and DNA replication. As a result, bacterial morphology is preserved. Bacteria are increasingly growing resistant to conventional antibiotics. Biocompatible and biodegradable ε-poly-L-lysine (EPL)/poly (e-caprolactone) (PCL) copolymer was designed and synthesized. The amphiphilic EPL-PCL copolymer could easily self-assembled into mono-dispersed nanoparticles (NPs), which showed a broad-spectrum antibacterial activity against E. coli, S. aureus and Bacillus subtilis (B. subtilis). The NPs have been found that they can disrupt bacterial walls/membranes and induce the increasing in reactive oxygen species and alkaline phosphatase levels. More importantly, the self-assembled NPs induced the changes in bacterial osmotic pressure, resulting in cell invagination to form holes and cause the leakage of cytoplasm.
Taken together, these results suggest that the EPL-PCL NPs can be further developed to be a promising antimicrobial agent to treat infectious diseases as surfactants and emulsifiers to enhance drug encapsulation efficiency and antimicrobial activity.
###
This work was supported by the National Basic Research Program of China (2012CB934000, 2011CB933400) and the National Natural Science Foundation of China (31325010, 21277037).
See the article:
Ruifang Zhao, Hai Wang, Tianjiao Ji, Greg Anderson, Guangjun Nie, Yuliang Zhao. Biodegradable cationic ε-poly-L-lysine-conjugated polymeric nanoparticles as a new effective antibacterial agent. Science Bulletin, 2015, 60(2): 216-226.
####
For more information, please click here
Contacts:
Nie Guangjun
Copyright © Science China Press
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||